Friday, July 10, 2026

Drug profile · INN

pegzilarginase

pegzilarginase (LOARGYS) is a l-arginine hydrolytic enzyme.

EMA: approved Alimentary tract and metabolism (A16) A16AB24
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — pegzilarginase
Class
Alimentary tract and metabolism (A16)
Route
Patents
0
Programs
1
Data quality
0.83

Quick answer

pegzilarginase (LOARGYS) is a l-arginine hydrolytic enzyme.

Key facts

INN pegzilarginase
Brand LOARGYS
Mechanism L-arginine hydrolytic enzyme
Target L-arginine
Therapeutic class Alimentary tract and metabolism (A16)
ATC code A16AB24

Mechanism of action

L-arginine hydrolytic enzyme

Primary target: L-arginine

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. Loargys 5 mg/ml solution for injection/infusion Phase 3 · Immedica Pharma AB · Arginase 1 deficiency (ARG1-D)

Related & competitor drugs

  1. agalsidase alfa Alimentary tract and metabolism (A16)
  2. alogliptin Alimentary tract and metabolism (A10)
  3. alogliptin benzoate Alimentary tract and metabolism (A10)
  4. aprepitant Alimentary tract and metabolism (A04)
  5. budesonide Alimentary tract and metabolism (A07)
  6. canagliflozin Alimentary tract and metabolism (A10)

Frequently asked questions

What is pegzilarginase?

pegzilarginase (LOARGYS) is a l-arginine hydrolytic enzyme.

What is the brand name for pegzilarginase?

LOARGYS is a marketed brand name for pegzilarginase. Check FDA Drugs@FDA for the current US label holder and prescribing information.